PopulationsHumans

Cardioprotective Effects of Sodium-Glucose Cotransporter-2 Inhibitors in Patients undergoing Ventricular Tachycardia (VT) Ablation: A Propensity-Matched Cohort Study

AHA Scientific Sessions 2025 Abstract

The paper

Muhammad Raffey Shabbir, Muhammad Osama, Ahmad Ullah Baig,

Rubab Zahra, Mahrukh Imtiaz,

Marshfield Clinic

AHA Scientific Sessions 2025 Abstract · 3 Nov 2025

Presented at AHA Scientific Sessions 2025 · Abstract 4357987

doi.org/10.1161/circ.152.suppl_3.4357987

Drug class linked to fewer deaths or complications in kidney disease
The American Journal of Cardiology · 8 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Diabetes & Vascular Disease Research · 4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Diabetes, Obesity & Metabolism · 4 Oct 2026
Early ablation is linked to lower cardiovascular risk after stroke
Neurology · 4 Oct 2026